微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 22.62% | -15.46% | -0.17% | 47/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 22.66% | -13.52% | 8.72% | 47/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 20.84% | -18.61% | -18.36% | 47/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
| 2023-12-31 | 25.53% | 3.19% | -4.59% | 47/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 26.76% | 3.79% | 2.13% | 46/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 26.2% | 1.16% | 2.32% | 45/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 25.61% | 6.32% | 3.5% | 46/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 24.74% | 57.5% | -4.02% | 46/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 25.78% | 105.65% | -0.46% | 45/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 25.9% | 121.89% | 7.53% | 46/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 24.09% | 94.56% | 53.33% | 43/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 15.71% | 1.08% | 25.31% | 48/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 12.54% | -29.96% | 7.4% | 46/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 11.67% | -35.1% | -5.72% | 47/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 12.38% | -35.05% | -20.34% | 38/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 15.54% | -18.3% | -13.17% | 48/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
| 2020-09-30 | 17.9% | -9.84% | -0.49% | 36/54 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
| 2020-06-30 | 17.99% | -9.5% | -5.63% | 44/54 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
| 2020-03-31 | 19.06% | -1.59% | 0.2% | 33/54 | 70.26% | 我武生物 | 95.6% | 行业排名> |
| 2019-12-31 | 19.02% | -13.31% | -4.18% | 43/54 | 72.44% | 我武生物 | 96.43% | 行业排名> |
| 2019-09-30 | 19.85% | -9.26% | -0.11% | 28/54 | 70.09% | 我武生物 | 96.51% | 行业排名> |
| 2019-06-30 | 19.87% | -4.92% | 2.61% | 27/54 | 69.35% | 我武生物 | 96.46% | 行业排名> |
| 2019-03-31 | 19.37% | -9.33% | -11.74% | 24/54 | 69.07% | 我武生物 | 96.44% | 行业排名> |
| 2018-12-31 | 21.95% | 3.19% | 0.3% | 37/54 | 71.54% | 康辰药业 | 95.1% | 行业排名> |
| 2018-09-30 | 21.88% | 2.86% | 4.67% | 23/54 | 67.51% | 康辰药业 | 94.98% | 行业排名> |
| 2018-06-30 | 20.9% | 1.35% | -2.14% | 24/54 | 67.2% | 康辰药业 | 94.9% | 行业排名> |
| 2018-03-31 | 21.36% | 2.65% | 0.44% | 21/54 | 65.03% | 我武生物 | 93.37% | 行业排名> |
| 2017-12-31 | 21.27% | 3.81% | -0.01% | 34/54 | -887.82% | 我武生物 | 96.35% | 行业排名> |
| 2017-09-30 | 21.27% | 8.37% | 3.12% | 21/54 | 65.93% | 我武生物 | 97% | 行业排名> |
| 2017-06-30 | 20.63% | 12.28% | -0.88% | 24/54 | 63.83% | 我武生物 | 96.96% | 行业排名> |
| 2017-03-31 | 20.81% | 31.05% | 1.58% | 20/54 | 65.37% | 我武生物 | 97.16% | 行业排名> |
| 2016-12-31 | 20.49% | 7.44% | 4.38% | 29/54 | 68.41% | 欧林生物 | 99.46% | 行业排名> |
| 2016-09-30 | 19.63% | 5.18% | 6.85% | 21/54 | 63.02% | 我武生物 | 95.96% | 行业排名> |
| 2016-06-30 | 18.37% | 6.73% | 15.68% | 23/54 | -3007.12% | 欧林生物 | 99.4% | 行业排名> |
| 2016-03-31 | 15.88% | -7.92% | -16.72% | 19/54 | 61.6% | 我武生物 | 95.8% | 行业排名> |
| 2015-12-31 | 19.07% | 1.57% | 2.18% | 27/54 | 65.23% | 欧林生物 | 99.33% | 行业排名> |
| 2015-09-30 | 18.66% | -6.99% | 8.42% | 20/54 | 60.32% | 我武生物 | 95.02% | 行业排名> |
| 2015-06-30 | 17.21% | -20.64% | -0.2% | 22/54 | 61.38% | 我武生物 | 94.71% | 行业排名> |
| 2015-03-31 | 17.25% | -22.77% | -8.14% | 18/54 | 57.69% | 我武生物 | 95.59% | 行业排名> |
| 2014-12-31 | 18.77% | -24.96% | -6.43% | 27/54 | 63.59% | 欧林生物 | 99.52% | 行业排名> |
| 2014-09-30 | 20.06% | -21.69% | -7.49% | 16/54 | 58.74% | 我武生物 | 95.83% | 行业排名> |
| 2014-06-30 | 21.69% | -16.33% | -2.88% | 16/54 | 57.05% | 我武生物 | 95.96% | 行业排名> |
| 2014-03-31 | 22.33% | -17.93% | -10.74% | 16/54 | 57.57% | 我武生物 | 96.38% | 行业排名> |